Atm reactivation reverses ataxia telangiectasia phenotypes in vivo

Area of Science:

• Genetics and Molecular Biology
• Cancer Research
• Immunology

Background:

• Hereditary DNA damage signaling deficiencies link to cancer, immunodeficiency, and aging.
• ATM kinase is crucial for DNA double-strand break repair; its deficiency causes ataxia telangiectasia (AT), a severe incurable disease.
• ATM is a promising target for gene therapy and transplantation strategies for AT.

Purpose of the Study:

• To develop and validate a novel tamoxifen-inducible Atm mouse model.
• To investigate the functional restoration of Atm in an Atm-deficient background.
• To explore therapeutic strategies for ATM activation in ataxia telangiectasia.

Main Methods:

• Generation of Atm tamoxifen-inducible mouse models.
• Induction of Atm expression via tamoxifen administration.
• Assessment of physiological and molecular parameters post-induction, including body weight, immunodeficiency, spermatogenesis, radioresistance, lifespan, tumor development, and cerebellar integrity.
• Evaluation of Atm signaling functionality in vitro and in vivo after DNA damage.

Main Results:

• Restoration of body weight, immunodeficiency, spermatogenesis, and radioresistance within one month of Atm induction.
• Significant doubling of lifespan and protection from thymoma in treated mice.
• Absence of cerebellar defects.
• Functional Atm signaling observed post-DNA damage both in vitro and in vivo.

Conclusions:

• The developed Atm-inducible mouse model effectively restores Atm function in Atm-deficient mice.
• This model validates Atm reconstitution as a viable strategy to ameliorate AT-related symptoms and extend lifespan.
• The model serves as a valuable platform for investigating novel therapeutic approaches targeting ATM activation for ataxia telangiectasia.